[1]
Gniaź, N. et al. 2024. Glucagon-like peptide-1 receptor agonists as a Therapeutic Option for Antipsychotic-Induced Obesity: A Review of Current Evidence. Journal of Education, Health and Sport. 75, (Dec. 2024), 56672. DOI:https://doi.org/10.12775/JEHS.2024.75.56672.